Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
74°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
July 16, 2025
Tags
Social issues
Eli Lilly and Co
Healthy Returns
From
CNBC.com News
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
July 09, 2025
Tags
Business News
Business
Biotechnology
From
CNBC.com News
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
July 08, 2025
Tags
Health care industry
Health & Science
Bristol/Myers Squibb Co
From
CNBC.com News
Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
June 25, 2025
Tags
Biotech and Pharmaceuticals
Healthy Returns
Social issues
From
CNBC.com News
5 things to know before the stock market opens Tuesday
June 24, 2025
Tags
Tesla Inc
Business
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%
June 23, 2025
Tags
Pharmaceuticals
US: News
Health care industry
From
CNBC.com News
Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition
June 11, 2025
Tags
Novo Nordisk A/S
Health care industry
Health & Science
From
CNBC.com News
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
May 21, 2025
Tags
LILLY DRN
Health Insurance
Biotech and Pharmaceuticals
From
CNBC.com News
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
May 19, 2025
Tags
Business News
Novo Nordisk A/S
Breaking News: Business
From
CNBC.com News
Novo Nordisk CEO to step down as competition weighs on Wegovy maker's share price
May 16, 2025
Tags
Europe News
Pharmaceuticals
Breaking News: Europe
From
CNBC.com News
Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down
May 15, 2025
Tags
Roche Holding AG
Europe: Top News And Analysis
AstraZeneca PLC
From
CNBC.com News
Why Americans pay so much more for prescription drugs
May 14, 2025
Tags
LILLY DRN
Pharmaceuticals
Biotechnology
From
CNBC.com News
Healthy Returns: Novo Nordisk’s Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance
May 07, 2025
Tags
Health & Science
Health care industry
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
May 07, 2025
Tags
Biotech and Pharmaceuticals
Roche Holding AG
Pharmaceuticals
From
CNBC.com News
How much a $1,000 investment in Hims & Hers at its IPO would be worth now
May 06, 2025
Tags
Make It: Next Gen Investing
Novo Nordisk A/S
Hims & Hers Health Inc
From
CNBC.com News
Hims & Hers brings former Amazon executive into C-suite
May 05, 2025
Tags
Novo Nordisk A/S
Technology
Enterprise
From
CNBC.com News
Cramer's week ahead: Earnings from Disney, Palantir and Uber
May 02, 2025
Tags
Walt Disney Co
Palantir Technologies Inc
Mad Money
From
CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
May 02, 2025
Tags
Biotechnology
Mergers
Novo Nordisk A/S
From
CNBC.com News
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
May 01, 2025
Tags
Pharmaceuticals
US: News
CVS Health Corp
From
CNBC.com News
Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth
April 29, 2025
Tags
Biotech and Pharmaceuticals
Business News
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
April 25, 2025
Tags
Biotech and Pharmaceuticals
Social issues
LILLY DRN
From
CNBC.com News
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
April 22, 2025
Tags
Biotech and Pharmaceuticals
Healthy Returns
Social issues
From
CNBC.com News
5 European stocks to watch this earnings season as Trump's tariffs hit
April 22, 2025
Tickers
OIL
Tags
Stellantis NV
Pharmaceuticals
Europe News
From
CNBC.com News
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
April 17, 2025
Tags
Viking Therapeutics Inc
Biotech and Pharmaceuticals
Roche Holding AG
From
CNBC.com News
CNBC Daily Open: Consumers are worried over the economy. The White House insists it’ll be fine
April 14, 2025
Tags
Novo Nordisk A/S
NVIDIA Corp
Daily Open
From
CNBC.com News
Pfizer scraps daily weight loss pill after liver injury in one patient
April 14, 2025
Tags
Biotech and Pharmaceuticals
LILLY DRN
Novo Nordisk A/S
From
CNBC.com News
Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback
April 10, 2025
Tags
Pharmaceuticals
Europe News
Breaking News: Economy
From
CNBC.com News
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
April 04, 2025
Tags
LILLY DRN
Social issues
Biotech and Pharmaceuticals
From
CNBC.com News
The biggest winners and losers in Europe as Trump announces sweeping tariffs
April 03, 2025
Tags
Heineken NV
Anheuser/Busch Inbev SA
Novo Nordisk A/S
From
CNBC.com News
Pharma tariff relief likely short-lived with sector-specific duties on the horizon
April 03, 2025
Tags
Novartis AG
Pharmaceuticals
Bavarian Nordic A/S
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.